These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 39231768

  • 1. [Analysis of the prognostic factors in primary plasma cell leukemia in the era of novel agents].
    Deng JJ, Jin XY, Zhang ZY, Zhou HX, Yang GZ, Geng CY, Jian Y, Chen WM, Gao W.
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jul 14; 45(7):645-650. PubMed ID: 39231768
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy and safety of gilteritinib-based combination therapy bridging allo-HSCT in relapsed or refractory acute myeloid leukemia patients with positive FLT3-ITD mutation].
    Xu Y, Zhang J, Xue SL, Miao M, Wang Y, Chen SN, Qiu HY, Wu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2024 Apr 14; 45(4):357-363. PubMed ID: 38951063
    [Abstract] [Full Text] [Related]

  • 3. Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
    Marson AG, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton CO, Hughes DA, Williamson PR, Baker G, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE.
    Health Technol Assess; 2021 Dec 14; 25(75):1-134. PubMed ID: 34931602
    [Abstract] [Full Text] [Related]

  • 4. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC, Chen CW, Yen HK, Lin YP, Lai CY, Wang JL, Groot OQ, Janssen SJ, Schwab JH, Hsu FM, Lin WH.
    Clin Orthop Relat Res; 2024 Dec 01; 482(12):2193-2208. PubMed ID: 39051924
    [Abstract] [Full Text] [Related]

  • 5. Survival Outcomes of Patients with Primary Plasma Cell Leukemia in the Era of Proteasome Inhibitors and Immunomodulatory Agents: A Real-Life Multicenter Analysis.
    Ataş Ü, Salim O, Iltar U, Yücel OK, Küçükdiler Eroğlu AH, Aslan V, Yıldırım M, Dedeoğlu Ö, Seçilmiş S, Ulaş T, Deveci B, Karaman Gulsaran S, Gedük A, Yaman F, Pınar İE, Maral S, Sarıcı A, Çelik S, Oğul H, Gülkan Özkan S, Gemici A, Güneş AK, Tombak A, Yavaşoğlu İ, Karakuş V, Cömert M, Toptaş T, Dal MS, Saba R, Kırkızlar HO, Mehtap Ö, Gündüz E, Özkalemkaş F, Albayrak M, Berber İ, Keklik M, Güler N, Özkan HA, Sevindik ÖG, Bolaman Z, Kurtoğlu E, Aylı M, Fıratlı Tuğlular T, Altuntaş F, Ündar L.
    Turk J Haematol; 2024 Dec 02; 41(4):225-235. PubMed ID: 39501735
    [Abstract] [Full Text] [Related]

  • 6. Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis.
    Yang Y, Chen W, Dong L, Duan L, Gao P.
    Clin Transl Oncol; 2024 Oct 02; 26(10):2488-2502. PubMed ID: 38625495
    [Abstract] [Full Text] [Related]

  • 7. [Clinical characteristics and prognosis of patients with myelodysplastic syndrome with a bone marrow nucleated erythroid cell proportion of greater than or equal to 50].
    Zeng YP, Li B, Qin TJ, Xu ZF, Qu SJ, Pan LJ, Gao QY, Jiao M, Wu JY, Wang HJ, Li CW, Ja YJ, Sun Q, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jul 14; 45(7):651-659. PubMed ID: 39231769
    [Abstract] [Full Text] [Related]

  • 8. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J, Gaudet LA, Saba S, Vandermeer B, Ashiq AR, Wingert A, Hartling L.
    Syst Rev; 2024 Nov 26; 13(1):289. PubMed ID: 39593159
    [Abstract] [Full Text] [Related]

  • 9. [Analysis of the efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome with blastomycosis and survival comparison of different subtypes after the WHO 2022 reclassification].
    Wang H, Ma RZ, Pang AM, Yang DL, Chen X, Zhang RL, Wei JL, Ma QL, Zhai WH, He Y, Jiang EL, Han MZ, Feng SZ.
    Zhonghua Xue Ye Xue Za Zhi; 2024 May 14; 45(5):445-452. PubMed ID: 38964918
    [Abstract] [Full Text] [Related]

  • 10. [Retrospective clinical study on cryopreservation-free integrated autologous hematopoietic stem cell transplantation model for newly diagnosed multiple myeloma].
    Yang X, Li CL, Chen J, Che FF, Xiao R, Li H, Huang J, Jiang T, Yang HQ, Wang H, Kuang XC, Huang XB.
    Zhonghua Xue Ye Xue Za Zhi; 2024 May 14; 45(5):488-494. PubMed ID: 38964924
    [Abstract] [Full Text] [Related]

  • 11. Hip Transposition Can Provide Early Walking Function After Periacetabular Tumor Resection: A Multicenter Study.
    Zhang L, Iwata S, Saito M, Nakagawa M, Tsukushi S, Yoshida S, Gokita T, Ae K, Nakashima S, Watanuki M, Akiyama T.
    Clin Orthop Relat Res; 2023 Dec 01; 481(12):2406-2416. PubMed ID: 37184605
    [Abstract] [Full Text] [Related]

  • 12. Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis.
    Curry N, Davenport R, Thomas H, Fox E, Lucas J, Evans A, Massou E, Sharma R, Shanmugaranjan S, Rourke C, Newton A, Deary A, Dallas N, Fitzpatrick-Creamer C, Podbielski JM, Wade CE, Edwards A, Benger J, Morris S, Cotton BA, Piercy J, Green L, Brohi K, Stanworth S.
    Health Technol Assess; 2024 Nov 01; 28(76):1-69. PubMed ID: 39545850
    [Abstract] [Full Text] [Related]

  • 13. Antioxidants for female subfertility.
    Showell MG, Mackenzie-Proctor R, Jordan V, Hart RJ.
    Cochrane Database Syst Rev; 2020 Aug 27; 8(8):CD007807. PubMed ID: 32851663
    [Abstract] [Full Text] [Related]

  • 14. Surgical Outcome of Low-Power-Density Blue Laser for Vascular Lesions of the Vocal Fold.
    Balouch B, Ranjbar PA, Alnouri G, Omari AIA, Martha V, Brennan M, Sataloff RT.
    J Voice; 2024 Nov 27; 38(6):1498-1506. PubMed ID: 35781175
    [Abstract] [Full Text] [Related]

  • 15. [Clinicopathologic characteristics and survival analysis of primary large B-cell lymphoma of the central nervous system].
    Xu QF, Shen R, Shen YG, Cao YW, Qian Y, Xu PP, Cheng S, Wang L, Zhao WL.
    Zhonghua Xue Ye Xue Za Zhi; 2024 May 14; 45(5):481-487. PubMed ID: 38964923
    [Abstract] [Full Text] [Related]

  • 16. [A multicenter, prospective, phaseⅡ, single-arm study on the treatment of newly diagnosed multiple myeloma with domestic bortezomib in combination with lenalidomide and dexamethasone].
    Xie LN, Wang X, He Q, Wang H, Ma J, Zhang HY, Liu N, Jie GT, Xiao TW, Zhang H, Zhang HG, Li ZJ, Xing LJ.
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jun 14; 45(6):571-576. PubMed ID: 39134489
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of human umbilical cord-derived mesenchymal stem cells versus placebo added to second-line therapy in patients with steroid-refractory acute graft-versus-host disease: a multicentre, randomized, double-blind, phase 2 trial.
    Jiang E, Qian K, Wang L, Yang D, Shao Y, Hu L, Li Y, Yao C, Han M, Hou X, Liu D.
    BMC Med; 2024 Nov 25; 22(1):555. PubMed ID: 39587570
    [Abstract] [Full Text] [Related]

  • 18. Infliximab for maintenance of medically-induced remission in Crohn's disease.
    Gordon M, Sinopoulou V, Akobeng AK, Sarian A, Moran GW.
    Cochrane Database Syst Rev; 2024 Feb 19; 2(2):CD012609. PubMed ID: 38372447
    [Abstract] [Full Text] [Related]

  • 19. Healthcare Resource Utilization and Associated Costs in Patients With Chronic Graft-Versus-Host Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation in England.
    Avenoso D, Davidson JA, Larvin H, Brewer HR, Rice CT, Ecsy K, Sil A, Skinner L, Hudson RDA.
    Transplant Cell Ther; 2024 Dec 19; 30(12):1207.e1-1207.e11. PubMed ID: 39389467
    [Abstract] [Full Text] [Related]

  • 20. High expression of malic enzyme 1 predicts adverse prognosis in patients with cytogenetically normal acute myeloid leukaemia and promotes leukaemogenesis through the IL-6/JAK2/STAT3 pathways.
    Zhang C, Li W, Wu F, Lu Z, Zeng P, Luo Z, Cao Y, Wen F, Li J, Chen X, Wang F.
    Ther Adv Hematol; 2024 Dec 19; 15():20406207241301948. PubMed ID: 39610460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.